Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 27 patents
56 readers on Mendeley
  • Article usage
  • Citations to this article (285)

Advertisement

Research Article Free access | 10.1172/JCI115584

Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

G D Roodman, N Kurihara, Y Ohsaki, A Kukita, D Hosking, A Demulder, J F Smith, and F R Singer

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Roodman, G. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Kurihara, N. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Ohsaki, Y. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Kukita, A. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Hosking, D. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Demulder, A. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Smith, J. in: JCI | PubMed | Google Scholar

Research Service, Audie Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

Find articles by Singer, F. in: JCI | PubMed | Google Scholar

Published January 1, 1992 - More info

Published in Volume 89, Issue 1 on January 1, 1992
J Clin Invest. 1992;89(1):46–52. https://doi.org/10.1172/JCI115584.
© 1992 The American Society for Clinical Investigation
Published January 1, 1992 - Version history
View PDF
Abstract

Pagetic osteoclasts are greatly increased in number and size and have increased numbers of nuclei per cell compared to normal osteoclasts. The mechanisms responsible for enhanced osteoclast formation in Paget's disease are unknown. We have used our recently described model system for pagetic osteoclast formation to evaluate culture media conditioned by these atypical multinucleated cells (MNC) to determine if pagetic osteoclasts produce an autocrine or paracrine factor that enhances osteoclast formation. Conditioned media from long-term bone marrow cultures from patients with Paget's disease stimulated osteoclast-like MNC formation in normal marrow cultures. At least part of this activity could be ascribed to interleukin 6 (IL-6). In contrast, conditioned media from normal marrow cultures contained lower levels of IL-6 and did not stimulate formation of osteoclast-like MNC. 7 of 8 bone marrow plasma samples taken from involved bones and 18 of 27 peripheral blood serum samples from Paget's patients had high levels of IL-6. Normal marrow plasma and peripheral blood serum had no or very low levels of IL-6. These results suggest that IL-6 produced by marrow and/or bone cells in patients with Paget's disease may be an autocrine/paracrine factor for pagetic osteoclasts.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 46
page 46
icon of scanned page 47
page 47
icon of scanned page 48
page 48
icon of scanned page 49
page 49
icon of scanned page 50
page 50
icon of scanned page 51
page 51
icon of scanned page 52
page 52
Version history
  • Version 1 (January 1, 1992): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (285)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 27 patents
56 readers on Mendeley
See more details